Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 826.00
-10.00 (-1.20%)
Sep 16, 2026, 3:30 PM JST
Kohjin Bio Employees
Kohjin Bio had 176 employees as of March 31, 2026. The number of employees increased by 9 or 5.39% compared to the previous year.
Employees
176
Change (1Y)
9
Growth (1Y)
5.39%
Revenue / Employee
26.67M JPY
Profits / Employee
727.27K JPY
Market Cap
4.27B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 176 | 9 | 5.39% |
| Mar 31, 2025 | 167 | 8 | 5.03% |
| Mar 31, 2024 | 159 | 20 | 14.39% |
| Mar 31, 2023 | 139 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Transgenic Group | 227 |
| Human Metabolome Technologies | 62 |
| Soiken Holdings | 49 |
| Ribomic | 25 |
| Noile-Immune Biotech | 23 |
| D. Western Therapeutics Institute | 19 |
| TMS Co., Ltd. | 18 |
| Modalis Therapeutics | 17 |